RPS6 and neoplasm: Finally, treatment of LKB1−/−NIC mice for 21 days with combination therapy showed the greatest impact on tumor volume and burden (Fig 3) with no change in the phosphorylation status of S6 compared with 2-DG treatment alone and Vehicle-treated mice (Fig. 5D).